本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Revolution Medicines, Inc.

40.38
-0.2900-0.71%
盘前40.14-0.2400-0.59%08:12 EDT
成交量:199.60万
成交额:8,067.50万
市值:75.07亿
市盈率:-11.29
高:41.17
开:40.22
低:39.20
收:40.67
数据加载中...
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/05

重要事件披露

Form 8-K - Current report
2024/12/04

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities